Paul S. Schulz, M.D.
Dr. Schulz received his Bachelor of Science in chemical engineering at University of Cincinnati, Ohio, in 1992 and his medical degree from the University of Louisville in 1999. He continued on with the University of Louisville School of Medicine to complete an internal medicine residency and infectious diseases fellowship in 2005. He remained on faculty until 2007 when he joined a private practice group. In 2010, Dr. Schulz joined Norton Healthcare and currently serves as the system epidemiologist participating in antimicrobial stewardship, infection prevention, and employee health. As part of the infectious diseases PGY2 program, he precepts the longitudinal ambulatory infectious diseases rotation and adult infectious diseases consult service. His current area of interest is HIV/hepatitis C co-infection.
Managing Editor
The first vaccine to prevent COVID-19 has been cleared for use in the United States. The Food and Drug Administration on Saturday granted emergency use authorization to Pfizer and BioNTech’s COVID-19 vaccine for use in individuals 16 years old and older. The first shipments began leaving facilities on Sunday.
The FDA’s decision was based on data from its Phase 3 clinical study, whose results were published last week in the New England Journal of Medicine and which saw a 95% vaccine efficacy rate. The two companies continue to gather additional data and prepare a biologics license application for full approval from the FDA in 2021.
Share this article
Share this article
WASHINGTON, Dec. 11, 2020 /PRNewswire/ The leaders of 18 pharmacy organizations today issued the following statement following the Food and Drug Administration s approval of the first Emergency use Authorization for the COVID-19 vaccine. We heartily welcome the decision by the US Food and Drug Administration (FDA) to authorize the emergency use of the first COVID-19 vaccine, following the recommendation of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). This is a historic moment in the nation s effort to end the pandemic. The pharmacy profession is ready to do its part as qualified, active participants in administering these vaccines in accordance with guidance issued by the FDA, CDC, HHS and state and local health departments, as well as increasing access for the American public to these important disease prevention tools.